CTSA
Lysosomal protective protein
Also known as: GSL, PPGB, PPGB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10619
- Gene
- CTSA
- Ensembl
- ENSG00000064601
- Chromosome
- 20
- Canonical length
- 480 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
480 residues, UniProt reviewed canonical sequence.
>P10619|CTSA
1 MIRAAPPPLF LLLLLLLLLV SWASRGEAAP DQDEIQRLPG LAKQPSFRQY SGYLKGSGSK
61 HLHYWFVESQ KDPENSPVVL WLNGGPGCSS LDGLLTEHGP FLVQPDGVTL EYNPYSWNLI
121 ANVLYLESPA GVGFSYSDDK FYATNDTEVA QSNFEALQDF FRLFPEYKNN KLFLTGESYA
181 GIYIPTLAVL VMQDPSMNLQ GLAVGNGLSS YEQNDNSLVY FAYYHGLLGN RLWSSLQTHC
241 CSQNKCNFYD NKDLECVTNL QEVARIVGNS GLNIYNLYAP CAGGVPSHFR YEKDTVVVQD
301 LGNIFTRLPL KRMWHQALLR SGDKVRMDPP CTNTTAASTY LNNPYVRKAL NIPEQLPQWD
361 MCNFLVNLQY RRLYRSMNSQ YLKLLSSQKY QILLYNGDVD MACNFMGDEW FVDSLNQKME
421 VQRRPWLVKY GDSGEQIAGF VKEFSHIAFL TIKGAGHMVP TDKPLAAFTM FSRFLNKQPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTSA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 312 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 312 nTPM
- colon: 169 nTPM
- kidney: 166 nTPM
- choroid plexus: 164 nTPM
- rectum: 161 nTPM
- parathyroid gland: 99 nTPM
Single-cell type
- platelets: 2,264 nCPM
- colonocytes: 325 nCPM
- enterocytes: 283 nCPM
- hofbauer cells: 247 nCPM
- esophageal apical cells: 203 nCPM
- kupffer cells: 182 nCPM
Immune cell
- eosinophil: 531 nTPM
- basophil: 482 nTPM
- total PBMC: 377 nTPM
- classical monocyte: 306 nTPM
- MAIT T-cell: 186 nTPM
- intermediate monocyte: 169 nTPM
Brain region
- choroid plexus: 126 nTPM
- thalamus: 77 nTPM
- white matter: 69 nTPM
- cerebellum: 59 nTPM
- hypothalamus: 58 nTPM
- medulla oblongata: 55 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTSA.
Disease | AllUniProt
Conditions CTSA is implicated in, by any mechanism.
- Galactosialidosis (GSL) MIM:256540
Disease | GeneticClinVar
80 pathogenic / likely-pathogenic of 624 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined deficiency of sialidase AND beta galactosidase
- GALACTOSIALIDOSIS, LATE INFANTILE
- GALACTOSIALIDOSIS, ADULT
- GALACTOSIALIDOSIS, EARLY INFANTILE
- Non-immune hydrops fetalis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein transport
- negative regulation of chaperone-mediated autophagy
- proteolysis
- regulation of chaperone-mediated autophagy
- regulation of protein stability
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S10, serine carboxypeptidase
- Serine carboxypeptidase, serine active site
- Alpha/Beta hydrolase fold
- Serine carboxypeptidase
- Serine carboxypeptidases, histidine active site
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTSA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTSA as an antibody target. Whether an autoantibody or antibody against CTSA could matter depends on whether native CTSA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTSA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTSA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...